Evidence map›Paper›PMID 38981590›Full record

ArticlePhysics in medicine and biology2024

GWO+RuleFit: rule-based explainable machine-learning combined with heuristics to predict mid-treatment FDG PET response to chemoradiation for locally advanced non-small cell lung cancer.

Chunyan Duan, Qiantuo Liu, Jiajie Wang, Qianqian Tong, Fangyun Bai, Jie Han, Shouyi Wang, Daniel S Hippe, Jing Zeng, Stephen R Bowen

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chunyan DuanDepartment of Mechanical Engineering, School of Mechanical Engineering, Tongji University, 4800 Cao'an Highway, Shanghai 201804, People's Republic of China.ORCID 0000-0002-9963-6900
Qiantuo LiuDepartment of Mechanical Engineering, School of Mechanical Engineering, Tongji University, 4800 Cao'an Highway, Shanghai 201804, People's Republic of China.
Jiajie WangDepartment of Mechanical Engineering, School of Mechanical Engineering, Tongji University, 4800 Cao'an Highway, Shanghai 201804, People's Republic of China.
Qianqian TongMaseeh Department of Civil, Architectural and Environmental Engineering, Cockrell School of Engineering, The University of Texas at Austin, 301 East Dean Keeton Street, Austin, TX 78712, United States of America.
Fangyun BaiShanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, 2209 Guangxing Road, Shanghai 201613, People's Republic of China.
Jie HanDepartment of Industrial, Manufacturing, and Systems Engineering, College of Engineering, The University of Texas at Arlington, 500 West First Street, Arlington, TX 76019, United States of America.
Shouyi WangDepartment of Industrial, Manufacturing, and Systems Engineering, College of Engineering, The University of Texas at Arlington, 500 West First Street, Arlington, TX 76019, United States of America.
Daniel S HippeClinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North, Seattle, WA 98109, United States of America.ORCID 0000-0003-2427-4404
Jing ZengDepartment of Radiation Oncology, School of Medicine, University of Washington, 1959 North East Pacific Street, Seattle, WA 98195, United States of America.
Stephen R BowenClinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Avenue North, Seattle, WA 98109, United States of America.ORCID 0000-0001-7581-770X

Funding

Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood AssaysR01CA258997 · NCI · UNIVERSITY OF WASHINGTON · PI Stephen R. Bowen, Jing Zeng · 2022 to 2026
$2.8M
Personalized radiation therapy through functional lung avoidance and response-adaptive dose escalation: utilizing multimodal molecular imaging to improve the therapeutic ratioR01CA204301 · NCI · UNIVERSITY OF WASHINGTON · PI BOWEN, STEPHEN R., ZENG, JING · 2016 to 2020
$2.3M
NCI NIH HHS R01 CA204301NCI NIH HHS R01 CA258997
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungChemoradiotherapyFluorodeoxyglucose F18Lung NeoplasmsMachine LearningPositron-Emission TomographyAgedFemaleHeuristicsHumansImage Processing, Computer-AssistedMaleMiddle AgedTreatment OutcomeFluorodeoxyglucose F18clustering methodsFDG PETlung cancermachine learningradiomicsrule-based modeltreatment response

Identifiers

PMID38981590
PMCPMC11338282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.